Neurocrine Bioscience buy Barclays PLC
Start price
16:15
/
50%
€109.95
Target price
09.09.25
€144.91
Performance (%)
-1.18%
Price
20:26
€108.65
Summary
This prediction is currently active. With a performance of -1.18%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 09.09.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -1.18% |
iShares Core DAX® | -3.429% |
iShares Nasdaq 100 | -6.121% |
iShares Nikkei 225® | -7.364% |
iShares S&P 500 | -4.366% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Barclays PLC from $180.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.00
02.08.24
02.08.24
€164.74
02.08.25
02.08.25
-21.83%
20:26
20:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-17.22%
20:26
20:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
-15.87%
20:26
20:26